• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA损伤诱导的铁死亡:一种调控p53和非编码RNA耐药性的布尔模型

DNA Damage-Induced Ferroptosis: A Boolean Model Regulating p53 and Non-Coding RNAs in Drug Resistance.

作者信息

Gupta Shantanu, Silveira Daner A, Mombach José Carlos M, Hashimoto Ronaldo F

机构信息

Instituto de Matemática e Estatística, Departamento de Ciência da Computação, Universidade de São Paulo, Rua do Matão 1010, São Paulo 05508-090, SP, Brazil.

Children's Cancer Institute, Porto Alegre 90620-110, RS, Brazil.

出版信息

Proteomes. 2025 Jan 20;13(1):6. doi: 10.3390/proteomes13010006.

DOI:10.3390/proteomes13010006
PMID:39846637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11755436/
Abstract

The tumor suppressor p53, in its wild-type form, plays a central role in cellular homeostasis by regulating senescence, apoptosis, and autophagy within the DNA damage response (DDR). Recent findings suggest that wild-type p53 also governs ferroptosis, an iron-dependent cell death process driven by lipid peroxidation. Post-translational modifications of p53 generate proteoforms that significantly enhance its functional diversity in regulating these mechanisms. A key target in this process is the cystine/glutamate transporter (xCT), which is essential for redox balance and ferroptosis resistance. Additionally, p53-induced miR-34c-5p suppresses cancer cell proliferation and drug resistance by modulating Myc, an oncogene further influenced by non-coding RNAs like circular RNA NOTCH1 (CricNOTCH1) and long non-coding RNA MALAT1. However, the exact role of these molecules in ferroptosis remains unclear. To address this, we introduce the first dynamic Boolean model that delineates the influence of these ncRNAs and p53 on ferroptosis, apoptosis, and senescence within the DDR context. Validated through gain- and loss-of-function perturbations, our model closely aligns with experimental observations in cancers such as oral squamous cell carcinoma, nasopharyngeal carcinoma, and osteosarcoma. The model identifies crucial positive feedback loops (CricNOTCH1/miR-34c/Myc, MALAT1/miR-34c/Myc, and Myc/xCT) and highlights the therapeutic potential of using p53 proteoforms and ncRNAs to combat drug resistance and induce cancer cell death.

摘要

肿瘤抑制因子p53的野生型形式通过在DNA损伤反应(DDR)中调节衰老、凋亡和自噬,在细胞稳态中发挥核心作用。最近的研究结果表明,野生型p53还调控铁死亡,这是一种由脂质过氧化驱动的铁依赖性细胞死亡过程。p53的翻译后修饰产生的蛋白变体在调节这些机制方面显著增强了其功能多样性。这一过程中的一个关键靶点是胱氨酸/谷氨酸转运体(xCT),它对氧化还原平衡和铁死亡抗性至关重要。此外,p53诱导的miR-34c-5p通过调节Myc抑制癌细胞增殖和耐药性,Myc是一种癌基因,还受到环状RNA NOTCH1(CricNOTCH1)和长链非编码RNA MALAT1等非编码RNA的进一步影响。然而,这些分子在铁死亡中的确切作用仍不清楚。为了解决这个问题,我们引入了第一个动态布尔模型,该模型描述了这些非编码RNA和p53在DDR背景下对铁死亡、凋亡和衰老的影响。通过功能获得和功能丧失扰动验证,我们的模型与口腔鳞状细胞癌、鼻咽癌和骨肉瘤等癌症的实验观察结果密切吻合。该模型确定了关键的正反馈回路(CricNOTCH1/miR-34c/Myc、MALAT1/miR-34c/Myc和Myc/xCT),并突出了使用p53蛋白变体和非编码RNA对抗耐药性和诱导癌细胞死亡的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/18fd1c2f781d/proteomes-13-00006-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/65fff165f813/proteomes-13-00006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/31ec6a4eb4e8/proteomes-13-00006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/ff56b09280d5/proteomes-13-00006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/680c94be3416/proteomes-13-00006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/d3ad9450c79d/proteomes-13-00006-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/18fd1c2f781d/proteomes-13-00006-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/65fff165f813/proteomes-13-00006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/31ec6a4eb4e8/proteomes-13-00006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/ff56b09280d5/proteomes-13-00006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/680c94be3416/proteomes-13-00006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/d3ad9450c79d/proteomes-13-00006-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a7/11755436/18fd1c2f781d/proteomes-13-00006-g006.jpg

相似文献

1
DNA Damage-Induced Ferroptosis: A Boolean Model Regulating p53 and Non-Coding RNAs in Drug Resistance.DNA损伤诱导的铁死亡:一种调控p53和非编码RNA耐药性的布尔模型
Proteomes. 2025 Jan 20;13(1):6. doi: 10.3390/proteomes13010006.
2
A dynamic Boolean network reveals that the BMI1 and MALAT1 axis is associated with drug resistance by limiting miR-145-5p in non-small cell lung cancer.一个动态布尔网络显示,在非小细胞肺癌中,BMI1和MALAT1轴通过限制miR-145-5p与耐药性相关。
Noncoding RNA Res. 2023 Oct 19;9(1):185-193. doi: 10.1016/j.ncrna.2023.10.008. eCollection 2024 Mar.
3
Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.lncRNA ANRIL 和 lncRNA UFC1 在非小细胞肺癌中癌基因作用的布尔网络模型的动力学分析。
Biomolecules. 2022 Mar 9;12(3):420. doi: 10.3390/biom12030420.
4
Unveiling the role of ferroptosis-associated exosomal non-coding RNAs in cancer pathogenesis.揭示铁死亡相关外泌体非编码 RNA 在癌症发病机制中的作用。
Biomed Pharmacother. 2024 Mar;172:116235. doi: 10.1016/j.biopha.2024.116235. Epub 2024 Feb 3.
5
MiR-34c-3p upregulates erastin-induced ferroptosis to inhibit proliferation in oral squamous cell carcinomas by targeting SLC7A11.miR-34c-3p 通过靶向 SLC7A11 上调依维莫司诱导的口腔鳞状细胞癌中的铁死亡来抑制增殖。
Pathol Res Pract. 2022 Mar;231:153778. doi: 10.1016/j.prp.2022.153778. Epub 2022 Jan 25.
6
LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response.LncRNA PTENP1/miR-21/PTEN 轴调控癌症中的 EMT 和耐药性:DNA 损伤反应中细胞命运的动态布尔建模。
Int J Mol Sci. 2024 Jul 29;25(15):8264. doi: 10.3390/ijms25158264.
7
c-Myc-induced circ-NOTCH1 promotes aggressive phenotypes of nasopharyngeal carcinoma cells by regulating the miR-34c-5p/c-Myc axis.c-Myc 诱导的 circ-NOTCH1 通过调控 miR-34c-5p/c-Myc 轴促进鼻咽癌细胞的侵袭表型。
Cell Biol Int. 2021 Jul;45(7):1436-1447. doi: 10.1002/cbin.11582. Epub 2021 Apr 6.
8
Silencing of lncRNA MALAT1 facilitates erastin-induced ferroptosis in endometriosis through miR-145-5p/MUC1 signaling.lncRNA MALAT1的沉默通过miR-145-5p/MUC1信号通路促进子宫内膜异位症中erastin诱导的铁死亡。
Cell Death Discov. 2022 Apr 11;8(1):190. doi: 10.1038/s41420-022-00975-w.
9
Up-regulation of miR-34c-5p inhibits nasopharyngeal carcinoma cells by mediating NOTCH1.miR-34c-5p 的上调通过调控 NOTCH1 抑制鼻咽癌细胞。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20200302.
10
FDX2, an iron-sulfur cluster assembly factor, is essential to prevent cellular senescence, apoptosis or ferroptosis of ovarian cancer cells.FDX2,一种铁硫簇组装因子,对防止卵巢癌细胞的细胞衰老、细胞凋亡或铁死亡是必不可少的。
J Biol Chem. 2024 Sep;300(9):107678. doi: 10.1016/j.jbc.2024.107678. Epub 2024 Aug 14.

引用本文的文献

1
Knockdown of MIR205HG prevents cell proliferation, migration and invasion through autophagy and ferroptosis pathways in lung adenocarcinoma.敲低MIR205HG可通过自噬和铁死亡途径抑制肺腺癌细胞的增殖、迁移和侵袭。
Transl Cancer Res. 2025 Jun 30;14(6):3587-3598. doi: 10.21037/tcr-2024-2335. Epub 2025 Jun 27.
2
The METTL3/IGF2BP1 axis-mediated m6 A modification of TRIM11 mRNA suppresses ferroptosis and accelerates malignant progression in non-small cell lung cancer cells by degrading ACSL4.METTL3/IGF2BP1轴介导的TRIM11 mRNA的m6A修饰通过降解ACSL4抑制非小细胞肺癌细胞中的铁死亡并加速恶性进展。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 16. doi: 10.1007/s00210-025-04207-7.
3

本文引用的文献

1
LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response.LncRNA PTENP1/miR-21/PTEN 轴调控癌症中的 EMT 和耐药性:DNA 损伤反应中细胞命运的动态布尔建模。
Int J Mol Sci. 2024 Jul 29;25(15):8264. doi: 10.3390/ijms25158264.
2
GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes.通过抑制xCT-GSH-GPX4途径导致的谷胱甘肽耗竭协同增强了二硫代二苯乙烯磺酸/铜诱导的骨髓增生异常综合征中的铜死亡。
Free Radic Biol Med. 2024 Sep;222:130-148. doi: 10.1016/j.freeradbiomed.2024.06.006. Epub 2024 Jun 11.
3
Plasma Circulating lncRNAs: MALAT1 and NEAT1 as Biomarkers of Radiation-Induced Adverse Effects in Laryngeal Cancer Patients.
血浆循环长链非编码RNA:MALAT1和NEAT1作为喉癌患者辐射诱导不良反应的生物标志物
Diagnostics (Basel). 2025 Mar 10;15(6):676. doi: 10.3390/diagnostics15060676.
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.
铁死亡在癌症中的作用:从分子机制到治疗策略。
Signal Transduct Target Ther. 2024 Mar 8;9(1):55. doi: 10.1038/s41392-024-01769-5.
4
The amino acid transporter SLC7A11 expression in breast cancer.乳腺癌中氨基酸转运蛋白 SLC7A11 的表达。
Cancer Biol Ther. 2024 Dec 31;25(1):2291855. doi: 10.1080/15384047.2023.2291855. Epub 2023 Dec 10.
5
The DUBA-SLC7A11-c-Myc axis is critical for stemness and ferroptosis.DUBA-SLC7A11-c-Myc 轴对干性和铁死亡至关重要。
Oncogene. 2023 Sep;42(36):2688-2700. doi: 10.1038/s41388-023-02744-0. Epub 2023 Aug 3.
6
Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy.肺癌中的铁死亡:一种调节细胞死亡的新途径及有前景的药物治疗靶点。
Cell Death Discov. 2023 Apr 1;9(1):110. doi: 10.1038/s41420-023-01407-z.
7
Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy.铁死亡中p53的翻译后修饰:癌症治疗的新型药理学靶点
Front Pharmacol. 2022 May 24;13:908772. doi: 10.3389/fphar.2022.908772. eCollection 2022.
8
TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling.TFAP2C介导的lncRNA PCAT1通过c-Myc/miR-25-3p/SLC7A11信号通路抑制多西他赛耐药前列腺癌中的铁死亡
Front Oncol. 2022 Mar 23;12:862015. doi: 10.3389/fonc.2022.862015. eCollection 2022.
9
Silencing of lncRNA MALAT1 facilitates erastin-induced ferroptosis in endometriosis through miR-145-5p/MUC1 signaling.lncRNA MALAT1的沉默通过miR-145-5p/MUC1信号通路促进子宫内膜异位症中erastin诱导的铁死亡。
Cell Death Discov. 2022 Apr 11;8(1):190. doi: 10.1038/s41420-022-00975-w.
10
Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.lncRNA ANRIL 和 lncRNA UFC1 在非小细胞肺癌中癌基因作用的布尔网络模型的动力学分析。
Biomolecules. 2022 Mar 9;12(3):420. doi: 10.3390/biom12030420.